Instil Bio (TIL) Total Non-Current Liabilities (2020 - 2026)

Instil Bio has reported Total Non-Current Liabilities for 7 years, with the latest figure at $90.3 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 8.17% year-over-year to $90.3 million in Q2 2026; TTM through Jun 2026 was $90.3 million, a 8.17% decrease from a year earlier, with the FY2025 full-year figure at $89.6 million, down 3.79% from the prior year.
• Total Non-Current Liabilities was $90.3 million for Q2 2026 at Instil Bio, up from $89.7 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $111.6 million in Q3 2022, with the low at $45.3 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $94.4 million, with a median of $94.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 268.78% in 2022, then fell 14.19% in 2023.
• Over 5 years, Total Non-Current Liabilities stood at $110.6 million in 2022, then declined by 14.19% to $94.9 million in 2023, then fell by 1.85% to $93.2 million in 2024, then declined by 3.79% to $89.6 million in 2025, then gained by 0.76% to $90.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $90.3 million (Q2 2026), $89.7 million (Q1 2026), and $89.6 million (Q4 2025), per Business Quant data.